No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | 1.92B | 39.81 | 511.70 | 31.18% | -33.24% | 3.91% | 0.14 | |
| GNFTGenfit S.A. | 313.52M | 6.27 | 209 | 134.56% | -14.12% | -31.42% | 4.54% | 0.90 |
| GYREGyre Therapeutics, Inc. | 741.77M | 7.70 | 154 | -6.78% | 6.2% | 4.84% | 0.02 | |
| TVRDTvardi Therapeutics, Inc. | 42.31M | 4.51 | -0.10 | -65.96% | -317.54% | -63.46% | ||
| UNCYUnicycive Therapeutics, Inc. | 134.75M | 6.27 | -1.12 | -100% | -89.15% | 0.10 | ||
| GLTOGalecto, Inc. | 38.32M | 23.95 | -1.29 | -237.68% | 0.00 | |||
| IVAInventiva S.A. | 1.17B | 6.12 | -1.73 | -47.37% | -13.75% | |||
| AKBAAkebia Therapeutics, Inc. | 355.59M | 1.34 | -4.06 | -17.7% | -7.07% | -38.24% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 527K | 284K | 118K | 69K | 30.84M | 765K | 80.07M | 20.2M | 28.57M | 67M |
| Revenue Growth % | -0.67% | -0.46% | -0.58% | -0.42% | 445.94% | -0.98% | 103.67% | -0.75% | 0.41% | 1.35% |
| Cost of Goods Sold | 1.93M | 1.99M | 2.23M | 1.85M | 177K | 202K | 161K | 248K | 341K | 300K |
| COGS % of Revenue | 3.66% | 6.99% | 18.89% | 26.87% | 0.01% | 0.26% | 0% | 0.01% | 0.01% | 0% |
| Gross Profit | -1.4M | -1.7M | -2.11M | -1.78M | 30.66M | 563K | 79.91M | 19.95M | 28.22M | 66.7M |
| Gross Margin % | -2.66% | -5.99% | -17.89% | -25.87% | 0.99% | 0.74% | 1% | 0.99% | 0.99% | 1% |
| Gross Profit Growth % | -7.68% | -0.21% | -0.24% | 0.15% | 18.18% | -0.98% | 140.93% | -0.75% | 0.41% | 1.36% |
| Operating Expenses | 16.27M | 32.46M | 54.58M | 67.7M | 88.67M | 78.35M | 53.54M | 47.5M | 54.8M | 63.42M |
| OpEx % of Revenue | 30.87% | 114.28% | 462.57% | 981.16% | 2.88% | 102.42% | 0.67% | 2.35% | 1.92% | 0.95% |
| Selling, General & Admin | 9.13M | 11.65M | 13.41M | 4.5M | 30.97M | 25.49M | 17.69M | 17.4M | 8.04M | 20.13M |
| SG&A % of Revenue | 17.32% | 41.04% | 113.61% | 65.14% | 1% | 33.32% | 0.22% | 0.86% | 0.28% | 0.3% |
| Research & Development | 5.39M | 19.19M | 35.09M | 47.66M | 66.17M | 59.1M | 35.17M | 35.82M | 46.71M | 47.21M |
| R&D % of Revenue | 10.23% | 67.56% | 297.42% | 690.74% | 2.15% | 77.25% | 0.44% | 1.77% | 1.64% | 0.7% |
| Other Operating Expenses | 1.75M | 1.61M | 6.08M | 6.41M | -8.47M | -6.23M | 682K | -5.72M | 53K | -3.92M |
| Operating Income | -17.68M | -34.16M | -56.7M | -69.48M | -57.83M | -82.9M | 31.82M | -27.29M | -26.58M | 3.28M |
| Operating Margin % | -33.54% | -120.27% | -480.47% | -1007.01% | -1.88% | -108.36% | 0.4% | -1.35% | -0.93% | 0.05% |
| Operating Income Growth % | -0.02% | -0.93% | -0.66% | -0.23% | 0.17% | -0.43% | 1.38% | -1.86% | 0.03% | 1.12% |
| EBITDA | -17.35M | -33.36M | -55.16M | -68.05M | -52.58M | -79.34M | 34.56M | -25.46M | -24.93M | 5M |
| EBITDA Margin % | -32.92% | -117.46% | -467.48% | -986.22% | -1.71% | -103.71% | 0.43% | -1.26% | -0.87% | 0.07% |
| EBITDA Growth % | -0.02% | -0.92% | -0.65% | -0.23% | 0.23% | -0.51% | 1.44% | -1.74% | 0.02% | 1.2% |
| D&A (Non-Cash Add-back) | 327K | 799K | 1.53M | 1.44M | 5.25M | 3.56M | 2.74M | 1.83M | 1.65M | 1.72M |
| EBIT | -17.68M | -34.16M | -56.69M | -69.53M | -54.28M | -76.58M | 32.16M | -27.64M | -23.89M | 6.62M |
| Net Interest Income | 437K | 193K | -1.94M | -10.79M | -8.83M | -10.35M | -4.68M | -4.27M | -2.94M | -3M |
| Interest Income | 437K | 316K | 389K | 202K | 2.63M | 1.44M | 274K | 137K | 1.71M | 1.79M |
| Interest Expense | 0 | 123K | 2.33M | 10.99M | 11.45M | 11.79M | 4.96M | 4.41M | 4.65M | 4.78M |
| Other Income/Expense | 541K | 526K | -2.45M | -10.39M | -7.89M | -18.75M | 37.66M | 3.45M | -1.93M | -1.43M |
| Pretax Income | -17.14M | -33.63M | -58.22M | -79.88M | -65.72M | -101.65M | 69.47M | -23.84M | -28.51M | 1.85M |
| Pretax Margin % | -32.51% | -118.42% | -493.38% | -1157.61% | -2.13% | -132.87% | 0.87% | -1.18% | -1% | 0.03% |
| Income Tax | 227K | 35K | 384K | -354K | -576K | -428K | 2.21M | -116K | 380K | 340K |
| Effective Tax Rate % | 1% | 1% | 1.01% | 1% | 0.99% | 1% | 0.97% | 1% | 1.01% | 0.82% |
| Net Income | -17.14M | -33.67M | -58.6M | -79.52M | -65.14M | -101.22M | 67.26M | -23.72M | -28.89M | 1.51M |
| Net Margin % | -32.51% | -118.55% | -496.64% | -1152.48% | -2.11% | -132.32% | 0.84% | -1.17% | -1.01% | 0.02% |
| Net Income Growth % | -0.01% | -0.96% | -0.74% | -0.36% | 0.18% | -0.55% | 1.66% | -1.35% | -0.22% | 1.05% |
| Net Income (Continuing) | -17.13M | -33.66M | -55.73M | -79.52M | -65.14M | -101.22M | 67.26M | -23.72M | -28.89M | 1.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.69 | -1.25 | -1.88 | -2.55 | -1.76 | -2.60 | 1.23 | -0.48 | -0.58 | 0.03 |
| EPS Growth % | 0.07% | -0.81% | -0.5% | -0.36% | 0.31% | -0.48% | 1.47% | -1.39% | -0.21% | 1.05% |
| EPS (Basic) | -0.69 | -1.28 | -1.88 | -2.55 | -1.76 | -2.60 | 1.50 | -0.48 | -0.58 | 0.03 |
| Diluted Shares Outstanding | 24.7M | 26.85M | 31.17M | 31.17M | 36.99M | 38.86M | 55.61M | 49.67M | 49.7M | 50.23M |
| Basic Shares Outstanding | 24.7M | 26.35M | 31.16M | 31.17M | 36.99M | 38.86M | 44.74M | 49.67M | 49.82M | 50.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 66.75M | 162M | 283.57M | 218.12M | 290.75M | 184.72M | 268.1M | 158.46M | 113.11M | 92.77M |
| Cash & Short-Term Investments | 60.11M | 152.28M | 273.82M | 207.24M | 276.75M | 171.03M | 258.76M | 140.55M | 77.79M | 81.79M |
| Cash Only | 60.11M | 152.28M | 273.82M | 207.24M | 276.75M | 171.03M | 258.76M | 136M | 77.79M | 81.79M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.55M | 0 | 0 |
| Accounts Receivable | 6.01M | 8.39M | 417K | 395K | 12.03M | 11.92M | 7.24M | 15.91M | 32.71M | 7.56M |
| Days Sales Outstanding | 4.16K | 10.79K | 1.29K | 2.09K | 142.43 | 5.69K | 32.99 | 287.48 | 417.93 | 41.21 |
| Inventory | 28K | 14K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
| Days Inventory Outstanding | 5.29 | 2.57 | 0.66 | 0.79 | 8.25 | 7.23 | 9.07 | 5.89 | 4.28 | 4.87 |
| Other Current Assets | -9K | 726K | 7.88M | 8.77M | -1K | 0 | 0 | 0 | 0 | 1K |
| Total Non-Current Assets | 2.5M | 4.22M | 9.61M | 11.36M | 19.1M | 13.9M | 13.62M | 57.08M | 60.76M | 58.66M |
| Property, Plant & Equipment | 1.32M | 3.01M | 6.32M | 7.76M | 16.45M | 11.65M | 9.02M | 8.21M | 7.87M | 7.59M |
| Fixed Asset Turnover | 0.40x | 0.09x | 0.02x | 0.01x | 1.87x | 0.07x | 8.88x | 2.46x | 3.63x | 8.82x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 562K | 667K | 636K | 795K | 920K | 791K | 174K | 43.96M | 48.76M | 48M |
| Long-Term Investments | 113K | 109K | 267K | 770K | 1.73M | 1.46M | 4.43M | 4.91M | 2.82M | 1.88M |
| Other Non-Current Assets | 7K | 433K | 1K | 2.03M | -1K | -11.95M | 3K | -55.78M | 1.3M | 1.18M |
| Total Assets | 69.26M | 166.21M | 293.18M | 229.48M | 309.85M | 198.61M | 281.72M | 215.54M | 173.87M | 151.42M |
| Asset Turnover | 0.01x | 0.00x | 0.00x | 0.00x | 0.10x | 0.00x | 0.28x | 0.09x | 0.16x | 0.44x |
| Asset Growth % | -0.2% | 1.4% | 0.76% | -0.22% | 0.35% | -0.36% | 0.42% | -0.23% | -0.19% | -0.13% |
| Total Current Liabilities | 8.61M | 17.56M | 27.11M | 39.25M | 43.49M | 31.07M | 62.84M | 39.37M | 38.48M | 75.16M |
| Accounts Payable | 5.28M | 13.34M | 19.05M | 32.65M | 32.75M | 20.34M | 12.3M | 8.61M | 10.45M | 18.39M |
| Days Payables Outstanding | 997.09 | 2.45K | 3.12K | 6.43K | 67.54K | 36.75K | 27.89K | 12.68K | 11.18K | 22.37K |
| Short-Term Debt | 1.22M | 1.17M | 2.74M | 2.64M | 2.42M | 2.26M | 1.1M | 4.05M | 6.85M | 55.44M |
| Deferred Revenue (Current) | 29K | 1K | 1K | 1K | 139K | 124K | 1000K | 1000K | 1000K | 0 |
| Other Current Liabilities | 2.09M | 2.97M | 378K | 112K | 5.56M | 1.03M | 313K | 61K | 40K | 39K |
| Current Ratio | 7.75x | 9.22x | 10.46x | 5.56x | 6.68x | 5.95x | 4.27x | 4.02x | 2.94x | 1.23x |
| Quick Ratio | 7.75x | 9.22x | 10.46x | 5.56x | 6.68x | 5.95x | 4.27x | 4.02x | 2.94x | 1.23x |
| Cash Conversion Cycle | 3.17K | 8.34K | -1.83K | -4.34K | -67.39K | -31.05K | -27.85K | -12.38K | -10.76K | -22.32K |
| Total Non-Current Liabilities | 5.23M | 5.86M | 161.85M | 169.29M | 182.29M | 183.71M | 99.79M | 81.64M | 67.44M | 7.04M |
| Long-Term Debt | 4.48M | 4.7M | 160.05M | 165.05M | 168.91M | 173.3M | 66.07M | 64.67M | 57.45M | 1.64M |
| Capital Lease Obligations | 0 | 307K | 1.47M | 1.38M | 10.17M | 8.05M | 5.98M | 5.53M | 4.81M | 3.92M |
| Deferred Tax Liabilities | 743K | 0 | 321K | 1.77M | 1.19M | 767K | 602K | 510K | 455K | 145K |
| Other Non-Current Liabilities | 742K | 849K | 937K | 1.08M | 2.02M | 1.6M | 1.32M | 1.23M | 978K | 1.34M |
| Total Liabilities | 13.84M | 23.42M | 188.95M | 208.54M | 225.79M | 214.78M | 162.62M | 121.01M | 105.92M | 82.2M |
| Total Debt | 5.71M | 6.25M | 163.75M | 169.59M | 183.62M | 185.69M | 74.23M | 75.28M | 70.18M | 62.13M |
| Net Debt | -54.41M | -146.03M | -110.07M | -37.66M | -93.13M | 14.66M | -184.52M | -60.73M | -7.61M | -19.66M |
| Debt / Equity | 0.10x | 0.04x | 1.57x | 8.10x | 2.18x | - | 0.62x | 0.80x | 1.03x | 0.90x |
| Debt / EBITDA | - | - | - | - | - | - | 2.15x | - | - | 12.41x |
| Net Debt / EBITDA | - | - | - | - | - | - | -5.34x | - | - | -3.93x |
| Interest Coverage | - | -277.71x | -24.31x | -6.32x | -5.05x | -7.03x | 6.42x | -6.19x | -5.72x | 0.69x |
| Total Equity | 55.42M | 142.8M | 104.23M | 20.94M | 84.06M | -16.16M | 119.1M | 94.53M | 67.95M | 69.22M |
| Equity Growth % | -0.21% | 1.58% | -0.27% | -0.8% | 3.01% | -1.19% | 8.37% | -0.21% | -0.28% | 0.02% |
| Book Value per Share | 2.24 | 5.32 | 3.34 | 0.67 | 2.27 | -0.42 | 2.14 | 1.90 | 1.37 | 1.38 |
| Total Shareholders' Equity | 55.42M | 142.8M | 104.23M | 20.94M | 84.06M | -16.16M | 119.1M | 94.53M | 67.95M | 69.22M |
| Common Stock | 5.99M | 7.79M | 7.79M | 7.8M | 9.71M | 9.72M | 12.45M | 12.46M | 12.46M | 12.5M |
| Retained Earnings | -68.63M | -102.32M | -161.13M | -238.42M | -303.48M | -404.85M | -337.82M | -361.27M | -389.79M | -390.57M |
| Treasury Stock | 0 | 0 | -127K | 0 | 0 | 0 | 0 | 0 | -970K | 0 |
| Accumulated OCI | 15K | 21K | -8K | 6K | 14K | -92K | 22K | -1.34M | 996K | 347K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -14.87M | -27.23M | -49.86M | -56.08M | -47.68M | -96.37M | 99.92M | -72.64M | -55.43M | 15.55M |
| Operating CF Margin % | -28.22% | -95.87% | -422.51% | -812.77% | -1.55% | -125.98% | 1.25% | -3.6% | -1.94% | 0.23% |
| Operating CF Growth % | 0.04% | -0.83% | -0.83% | -0.12% | 0.15% | -1.02% | 2.04% | -1.73% | 0.24% | 1.28% |
| Net Income | -17.14M | -33.67M | -58.6M | -79.52M | -65.14M | -101.22M | 67.26M | -23.72M | -28.89M | 1.51M |
| Depreciation & Amortization | 327K | 816K | 1.41M | 1.82M | 5.41M | 3.56M | 2.74M | 1.83M | 1.65M | 1.72M |
| Stock-Based Compensation | 2.01M | 11K | 278K | 787K | 1.66M | 1.24M | 470K | 245K | 578K | 0 |
| Deferred Taxes | 3K | 35K | 384K | -354K | -576K | -428K | 2.21M | -116K | 380K | 0 |
| Other Non-Cash Items | -17K | -321K | 1.39M | 10.5M | 11.33M | 11.61M | -32.45M | 3.91M | -1.33M | 3.88M |
| Working Capital Changes | -60K | 5.9M | 5.28M | 10.33M | -356K | -11.13M | 59.68M | -54.79M | -27.82M | 8.43M |
| Change in Receivables | 946K | -2.94M | -2.11M | -724K | -1.64M | 318K | 4.34M | -8.56M | -17.42M | 23.96M |
| Change in Inventory | 219K | 14K | 10K | 0 | 0 | 0 | 0 | 0 | 17.42M | 0 |
| Change in Payables | -1.46M | 8.83M | 7.38M | 11.06M | 1.28M | -11.45M | 55.34M | -46.23M | -10.4M | -15.53M |
| Cash from Investing | 3.5M | -2.09M | -2.95M | -3.99M | 327K | -966K | -3.38M | -46.27M | 2.23M | -1.04M |
| Capital Expenditures | -790K | -2.04M | -2.8M | -2.94M | -2.03M | -900K | -537K | 0 | -2.49M | -979K |
| CapEx % of Revenue | 1.5% | 7.17% | 23.73% | 42.58% | 0.07% | 1.18% | 0.01% | - | 0.09% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 4.29M | 1K | -148K | 2K | 2.52M | 0 | 308K | 271K | 172K | 80K |
| Cash from Financing | -520K | 121.48M | 174.35M | -6.51M | 116.86M | -8.26M | -8.92M | -3.79M | -5.1M | -10.57M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 280K | 7K | -1.33M | -6.31M | -7.74M | -6.32M | -1.83M | -2.04M | -493K | -1.46M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -15.66M | -29.26M | -52.66M | -59.02M | -49.71M | -97.27M | 99.38M | -72.64M | -57.92M | 14.22M |
| FCF Margin % | -29.72% | -103.04% | -446.24% | -855.35% | -1.61% | -127.15% | 1.24% | -3.6% | -2.03% | 0.21% |
| FCF Growth % | 0.03% | -0.87% | -0.8% | -0.12% | 0.16% | -0.96% | 2.02% | -1.73% | 0.2% | 1.25% |
| FCF per Share | -0.63 | -1.09 | -1.69 | -1.89 | -1.34 | -2.50 | 1.79 | -1.46 | -1.17 | 0.28 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.81x | 0.85x | 0.71x | 0.73x | 0.95x | 1.49x | 3.06x | 1.92x | 10.32x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -27.23% | -33.97% | -47.45% | -127.06% | -124.08% | -298.13% | 130.68% | -22.21% | -35.57% | 2.2% |
| Return on Invested Capital (ROIC) | -1305.85% | - | - | - | - | - | - | -60.55% | -42.35% | 4.48% |
| Gross Margin | -266.41% | -598.94% | -1788.98% | -2586.96% | 99.43% | 73.59% | 99.8% | 98.77% | 98.81% | 99.55% |
| Net Margin | -3251.42% | -11854.58% | -49664.41% | -115247.83% | -211.24% | -13231.5% | 84% | -117.45% | -101.15% | 2.25% |
| Debt / Equity | 0.10x | 0.04x | 1.57x | 8.10x | 2.18x | - | 0.62x | 0.80x | 1.03x | 0.90x |
| Interest Coverage | - | -277.71x | -24.31x | -6.32x | -5.05x | -7.03x | 6.42x | -6.19x | -5.72x | 0.69x |
| FCF Conversion | 0.87x | 0.81x | 0.85x | 0.71x | 0.73x | 0.95x | 1.49x | 3.06x | 1.92x | 10.32x |
| Revenue Growth | -67.36% | -46.11% | -58.45% | -41.53% | 44594.2% | -97.52% | 10366.54% | -74.78% | 41.45% | 134.56% |
Genfit S.A. (GNFT) has a price-to-earnings (P/E) ratio of 209.0x. This suggests investors expect higher future growth.
Genfit S.A. (GNFT) reported $116.8M in revenue for fiscal year 2024. This represents a 4847% increase from $2.4M in 2011.
Genfit S.A. (GNFT) grew revenue by 134.6% over the past year. This is strong growth.
Genfit S.A. (GNFT) reported a net loss of $16.5M for fiscal year 2024.
Genfit S.A. (GNFT) has a return on equity (ROE) of 2.2%. This is below average, suggesting room for improvement.
Genfit S.A. (GNFT) had negative free cash flow of $47.2M in fiscal year 2024, likely due to heavy capital investments.